Advances in the Management of pH-Positive Leukemia

Hematology-Live > Malignant
Advances in the Management of pH-Positive Leukemia
26
Mar

Speaker: Dr. Elias Jabbour Affiliations: Professor of Medicine in the Department of Leukemia, University of Texas MD Anderson Cancer Center, United States   This topic was presented during the Emirates Society of Haematology virtual educational series hosted in 2020.

New Approaches to First-Line Management in Follicular Lymphoma
26
Mar

Speaker: Dr. Andrew Davies Affiliations: Director, Southampton Experimental Cancer Medicine Center, United Kingdom   This topic was presented during the Emirates Society of Haematology virtual educational series hosted in 2022.

Updates in the Management of Chronic Lymphocytic Leukemia
26
Mar

Speaker: Dr. John M. Pagel Affiliations: Chief of Hematologic Malignancies, Swedish Cancer Institute, United States   This topic was presented during the Emirates Society of Haematology virtual educational series hosted in 2022.

Outcomes of Giliteritinib in R/R AML with FLT3 Positive Mutation
26
Mar

Speaker: Dr. Pau Montesinos Affiliations: Attending Physician in Department of Hematology, University Hospital La Fe, Valencia, Spain   This topic was presented during the Emirates Society of Haematology virtual educational series hosted in 2022.

Optimising Treatment Decisions with New Therapies for Patients with Acute Myeloid Leukemia
26
Mar

Speaker: Dr. Amar Lal Affiliations: Consultant Hematologist, Tawam Hospital, Al Ain, United Arab Emirates   This topic was presented during the Emirates Society of Haematology virtual educational series hosted in 2022

Relapsed Refractory Mutliple Myeloma: An Update
26
Mar

Speaker: Dr. Khalil Al Farsi Affiliations: Senior Consultant in the Hematology/BMT Department, Sultan Qaboos University Hospital, Muscat, Oman   This topic was presented during the Emirates Society of Haematology virtual educational series hosted in 2022.

Implementing Multiple Myeloma Clinical Trial Data Real-World practice: Tawam case Based Discussion
26
Mar

Speaker: Dr. Amar Lal Affiliations: Consultant Hematologist, Tawam Hospital, Al Ain, United Arab Emirates   This topic was presented during the Emirates Society of Haematology virtual educational series hosted in 2021.

Integrating Immunotherapy in the Therapy of Acute Lymphocytic Leukemia
25
Mar

Speaker: Dr. Elias Jabbour Affiliations: Professor of Medicine in the Department of Leukemia, University of Texas MD Anderson Cancer Center, United States   This topic was presented during the Emirates Society of Haematology virtual educational series hosted in 2020

How to Treat the Toxicities of Pegasparaginase in Adults with Acute Lymphoblastic Leukemia
25
Mar

Speaker: Dr. Dan Douer Affiliations: Associate Professor of Medicine in the Division of Hematology, University of Southern California, United States   This topic was presented during the Emirates Society of Haematology virtual educational series hosted in 2020.

eaccme

Accreditation Statement

The Hematology Live Online Education, made available on https://hematologylive.online/ and organized by Meeting Minds Experts, is accredited by the European Accreditation Council for Continuing Medical Education (EACCME) to provide the following CME activity for medical specialists.

 

Each medical specialist should claim only those credits that he/she actually spent in the educational activity. The EACCME is an institution of the European Union of Medical Specialists (UEMS). Only those e-learning materials that are displayed on the UEMSEACCME website have formally been accredited.

 

Through an agreement between the European Union of Medical Specialists (UEMS) and the American Medical Association (AMA), physicians may convert EACCME credits to an equivalent number of AMA PRA Category 1 CreditsTM. Information on the process to convert EACCME credit to AMA credit can be found at www.ama-assn.org/education/earn-credit-participation-international-activities.